Search

Issue
Title
Authors
Comorbid conditions in patients with chronic heart failure (according to the registry of chronic heart failure in the Tyumen region)
Airapetian A.A., Lazareva N.V., Reitblat O.M., Mezhonov E.M., Evgeny E.V., Prints Y.S., Zhirov I.V., Tereshchenko S.N., Boytsov S.A.
Pentraxin-3 – a promising biological marker in heart failure: literature review
Alieva A.M., Teplova N.V., Batov M.A., Voronkova K.V., Valiev R.K., Shnakhova L.M., Pinchuk T.V., Rakhaev A.M., Kalova M.R., Nikitin I.G.
Exogenous ketone therapy for heart failure: A review
Aksenova Y.O., Osmolovskaya Y.F., Zhirov I.V., Beniashvili A.G., Morozova M.A., Tereshchenko S.N.
Endocan is a key player in cardiovascular disease: A review
Alieva A.M., Reznik E.V., Baykova I.E., Teplova N.V., Makeeva L.M., Voronkova K.V., Khadzhieva N.K., Modestova A.V., Totolyan G.G., Valiev R.K., Li A.M., Kotikova I.A., Nikitin I.G.
The effect of active diuretic therapy on the sodium balance in patients with acute decompensation of chronic heart failure
Davydov V.V., Arehina E.L.
Difference of genetic polymorphisms in patients with type 2 diabetes mellitus with absence or presence of chronic heart failure with preserved ejection fraction
Sveklina T.S., Shustov S.B., Kolyubaeva S.N., Kuchmin A.N., Kozlov V.A., Halimov Y.S., Konyaev V.V.
A clinical case of hereditary transthyretin amyloidosis. Case report
Shoshina A.A., Nasonova S.N., Zhirov I.V., Saidova M.A., Ansheles A.A., Meshkov A.N., Tereshchenko S.N.
Acute decompensated heart failure. What has changed in the clinical guidelines in 2021?
Zhirov I.V., Nasonova S.N., Khalilova U.A., Osmolovskaya Y.F., Zhirova I.A., Gimadiev R.R., Chaikovskaia O.I., Reitblat O.M., Prints I.S., Kochetov A.G., Tereshchenko S.N.
Therapy correction of concerned chronic heart failure and chronic obstructive pulmonary disease in a patient with first identified pulmonary tuberculosis. Case report
Bagisheva N.V., Mordyk A.V., Trukhan D.I., Viktorova I.A., Moiseeva M.V.
Acute heart failure: classification, diagnosis, general approaches to treatment
Zhirov I.V., Nasonova S.N., Khalilova U.A., Osmolovskaya Y.F., Chaikovskaia O.I., Zhirova I.A., Gimadiev R.R., Kochetov A.G., Tereshchenko S.N.
Safety of dapagliflozin initiation in acute decompensated heart failure patients with reduced left ventricular ejection fraction
Poskakalova A.E., Nasonova S.N., Zhirov I.V., Tereshchenko S.N.
Neopterin is a biomarker of chronic heart failure (review of modern literature)
Alieva A.M., Pinchuk T.V., Voronkova K.V., Shnakhova L.M., Ettinger O.A., Akhmedova M.F., Valiev R.K., Kalova M.R., Gasanova E.T., Nikitin I.G.
Molecular mechanisms of inflammation in the development of heart failure: A review
Buziashvili Y.I., Asymbekova E.U., Tugeeva E.F., Rakhimov A.Z., Shakhnazaryan L.S., Akildzhonov F.R.
Tumor necrosis factor gene polymorphism rs1800629 in patients with atherosclerotic cardiovascular diseases: A review
Khazova E.V., Bulashova O.V., Valeeva E.V.
Study of the rs1800795 polymorphism of the IL6 gene to verify the clinical portrait of a patient with chronic heart failure: gender aspects
Khazovа E.V., Boulashova O.V., Valeeva E.V.
Rational drug therapy of chronic heart failure: the role of mineralocorticoid receptor antagonists: review
Safronova N.V., Zhirov I.V., Tereshchenko S.N.
Heart failure as a complication of myocardial infarction: rational therapy. Case report
Zhirov I.V., Safronova N.V., Tereshchenko S.N.
Chronic heart failure – modification of treatment paradigm
Nasonova S.N., Zhirov I.V., Tereshchenko S.N.
Catestanin – a promising biological marker for heart failure: A review
Alieva A.M., Teplova N.V., Reznik E.V., Ettinger O.A., Faradzhov R.A., Khachirova E.A., Kovtiukh I.V., Kotikova I.A., Sysoeva D.A., Bigushev I.R., Nikitin I.G.
Non-alcoholic fatty liver disease and cardiovascular risks: A review
Kotovskaya Y.V.
Management of a patient with dyspnea on an outpatient admission
Vertkin A.L., Topolyansky A.V., Knorring G.Y., Shamuilova M.M.
Asthma and cardiovascular disease
Ostroumova O.D., Goloborodova I.V., Voevodina N.Y., Fomina V.M., Seregin A.A.
Effectiveness and safety of bronchodilator use in chronic cardiac insufficiency of ischemic genesis comorbid with chronic obstructive pulmonary disease
Evdokimov V.V., Evdokimova A.G., Kovalenko E.V., Voronina G.V.
POSSIBILITIES OF PHARMACEUTICAL TREATMENT OF CARDIOGENIC ENCEPHALOPATHY WITH THE USE OF RUSSIAN MEDICATION WITH METABOLIC ACTION LEVOCARNITINE IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CONGESTIVE HEART FAILURE
Mozheiko M.E., Bushueva E.V., Potanina M.V., Ryabikhin E.A.
Trimetazidine (review of the latest foreign publications)
Akatova E.V.
Efficacy and safety of long-term use of prolonged bronchodilators in patients with cardiopulmonary pathology and chronic heart failure
Evdokimov V.V., Yushchuk E.N., Evdokimova A.G., Stryuk R.I.
Captopril effectiveness in treatment of patients with congestive heart failure and cardiopulmonary pathology
Evdokimov V.V., Evdokimova A.G., Kovalenko E.V., Tereshchenko O.I.
Inhibitor If-sinus channels ivabradine - a drug, increases the effectiveness of treatment of chronic heart failure and coronary heart disease
Trukhan D.I.
Ventricular arrhythmias in chronic heart failure: features of treatment and the possibility of improving the prognosis
Bunin Y.A., Zolozova E.A.
Fractalkin and cardiovascular disease
Alieva A.M., Almazova I.I., Pinchuk T.V., Reznik E.V., Rakhaev A.M., Nikitin I.G.
TORASEMIDE - THE DRUG FOR THE TREATMENT OF HEART FAILURE AND ARTERIAL HYPERTENSION
Trukhan D.I., Davydov E.L.
The place of antagonists of mineralocorticoid receptors in the treatment of chronic heart failure
Orlova N.V., Spiryakina Y.G.
Principles of drug therapy of arterial hypertension
Zadionchenko V.S., Shekhyan G.G., Yalymov A.A., Shchikota A.M.
Heart damage in arterial hypertension. Management of hypertension and contractile dysfunction
Gurevich M.A., Kuzmenko N.A.
Mineralocorticoid receptor antagonists: a dubious past and advanced future
Napalkov D.A.
Captopril in cardiological patients treatment: is there still place for the “first of the Mohicans”?
Valikulova F.Y., Koroleva L.Y., Melnichenko O.V., Duryndina E.M., Muradova F.N., Alekseeva M.M.
Sodium-glucose co-transporter-2 inhibitors in patients with heart failure. What's new? What are the prospects?
Erlikh A.D., Riabova D.V.
Cystatin C allows to detect early progression of chronic kidney disease in patients with acute decompensation of chronic heart failure
Davydov V.V., Arechina E.L.
Vybor effektivnogo diuretika dlya terapii khronicheskoy serdechnoy nedostatochnosti na ambulatornom etape: dovody v pol'zu torasemida
Larina V.N.
Angiotensin receptor blockers II in the treatment of arterial hypertension in patients with comorbid pathology: the possibilities of candesartan
Trukhan D.L., Davydov E.L.
Therapy for chronic heart failure: the possibilities of eplerenone
Vertkin A.L., Abdullaeva A.U., Knorring G.Y.
The application of calcium channel blockers in patients with cardiovascular disease: focus on the diltiazem
Zadionchenko V.S., Shehyan G.G., Yalymov A.A., Schikota A.M., Sherstyannikova O.M., Asymbekova E.U.
Antagonists of mineralocorticoid receptors in the treatment of patients with post-infarced heart failure: the role of eplerenon
Kashtalap V.V., Sedykh D.Y., Barbarash O.L.
Hyperuricemia and chronic heart failure: risk factors and prognostic parallels
Larina V.N., Larin V.G.
Algorithm for antihypertensive therapy choice: focus on candesartan
Shekhyan G.G., Yalymov A.A., Shchikota A.M., Timofeeva N.Y., Zadionchenko V.S., Terpigorev S.A., Nikishenkov A.M., Kabanova T.G.
Edema pharmacotherapy in patients with hepatic cirrhosis and congestive heart failure: loop diuretics in focus
Ketova G.G., Popov A.Y., Babich A.E., Luchinina E.V.
Correction of late violations of atrioventricular conduction in patients with lower myocardial infarction: the case of ivabradin
Loukianova I.Y., Shishkin A.N.
The characteristics of torasemide - loop diuretic application in patients with compensated heart failure
Ovchinnikov A.G.
Dinical value of blood biomarker ST2 in patients with chronic heart failure
Alieva A.M., Pinchuk T.V., Almazova I.I., Ettinger O.A., Valiev R.K., Batov M.A., Nikitin I.G.
Management of patients with chronic heart failure and diabetes mellitus from the standpoint of modern recommendations and in real clinical practice
Reznik E.V., Lazarev V.A., Kalova M.R., Nikitin I.G.
PREVENTION AND OVERCOMING OF CARDIOTOXIC EFFECT OF CANCER THERAPY. INTERVIEW
Anxiety and depressive disorders in cardiology practice. Possibilities of using D,L-Hopantenic acid
Ostroumova O.D., Goloborodova I.V., Fomina V.M., Bondarets O.V.
Chronic obstructive pulmonary disease and comorbid cardiovascular disease: in the context of guidelines
Ostroumova O.D., Kochetkov A.I.
Treatment of chronic heart failure and arterial hypertension: two aims and one drug - torasemide
Trukhan D.I.
Non-compact myocardium of the left ventricle: secondary prevention of thromboembolic complications
Myasnikov R.P., Kulikova O.V., Kharlap M.S., Koretskiy S.N., Andreenko E.Y., Mershina E.A., Sinitsyn V.E., Boytsov S.A.
Chronic heart failure in the practice of the therapist: is it difficult to recognize it?
Kirichenko A.A., Ebseeva E.Y.
Heart failure and contrast-induced acute kidney injury in patients with coronary artery disease
Mironova O.I., Sivakova O.A., Deev A.D., Fomin V.V.
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: A CHOICE OF THE DRUG IN CLINICAL PRACTICE GIVEN THE EFFECTIVENESS AND SAFETY OF USE
Mubarakshina O.A., Liubavskaia S.S., Somova M.N., Batishcheva G.A.
Amyloid heart disease: pathomorphology, diagnostic approaches and treatment options
Rameeva A.S., Rameev V.V., Moiseev S.V., Tao P.P., Kozlovskaya L.V.
Treatment of chronic heart failure and arterial hypertension: two aims and one drug - fosinopril
Trukhan D.I.
The role of antagonists of mineralocorticoid receptors in the pharmacotherapy of chronic heart failure
Batishcheva G.A., Mubarakshina O.A., Somova M.N., Dronova Y.M.
Modern possibilities of torasemide application in clinical practice
Batishcheva G.A., Mubarakshina O.A., Somova M.N., Evstigneeva A.S.
Angiotensin II receptor antagonist - candesartan in the arsenal of therapist
Kirichenko A.A.
Key features of candesartan application in clinical practice
Evdokimova A.G., Lozhkina M.V., Kovalenko E.V.
The relevance of prescribing triple neurohormonal blockade in real clinical practice: the role of mineralocorticoid receptor antagonists
Zhirov I.V.
P2-ADRENERGIC RECEPTORS GENETIC POLYMORPHISM, CARDIOVASCULAR DISORDERS AND INFLUENCE OF P-BLOCKERS’ EFFECTIVENESS
Leonova M.V.
Decreased cardiac mortality with nicorandil in patients with ischemic heart failure
Yoshihisa A., Sato Y., Watanabe S., Yokokawa T., Sato T., Suzuki S., Oikawa M., Kobayashi A., Takeishi Y.
The mineralocorticoid receptor blockers in the treatment of chronic heart failure
Kirichenko A.A.
Clinical aspects of application of candesartan
Rybachkova Y.V.
Liver damage in patients with ischemic chronic heart and type 2 diabetes - a treacherous tandem: possible additional organoprotective therapy
Statsenko M.E., Turkina S.V., Shilina N.N.
The characteristics of torasemide application in patients with arterial hypertension and chronic heart failure
Evdokimov V.V., Evdokimova A.G., Lozhkina M.V., Tebloev K.I.
Age aspects of acute myocardial infarction
Khorolets E.V., Shlyk S.V., Bychkova O.I.
Cardiology 2020. The patient with chronic heart failure: a new trajectory of life
Insulin resistance: focus on the pathogenesis of cardiomyopathy
Shishkova V.N., Martynov A.I.
COMPARATIVE PHARMACOEPIDEMIOLOGICAL CHARACTERISTICS OF THE PRESCRIPTIONS OF MEDICINES APPLIED AT PATIENTS WITH CHRONIC HEART FAILURE IN THE CONDITIONS OF TYPICAL PRACTICE OF KURSK AND CHISINAU
Povetkin S.V., Ghicavii V.I., Klyueva E.G., Batchinschi N.G., Pjdgurschi L.A., Turcan L.M.
Cognitive disorders in medical rehabilitation
Krasnov V.S., Shmonin A.A., Maltseva M.N., Melnikova E.V., Ivanova G.E.
Effect of nicorandil on the quality of life and course of the disease in patients with heart failure in ischemic heart disease
Makarovskaya V.V., Ryazanov A.S., Kudryavtsev A.A., Kapitonov K.I.
Modern approaches to the use of torasemide in cardiovascular diseases
Baryshnikova G.A., Chorbinskaya S.A., Stepanova I.I.
Pathogenetic substantiation inclusion of taurine in the treatment of patients with diabetes mellitus type 2
Statsenko M.E., Turkina S.V., Tyshchenko I.A., Gorbacheva E.E.
The arsenal of therapist: torasemide
Kirichenko A.A.
Efficacy and safety in clinical practice fosinopril
Stryuk R.I.
Reducing the risk of chronic heart failure development in patients with arterial hypertension from the position of evidence medicine (focus on candesartan)
Evdokimova A.G., Stryuk R.I., Evdokimov V.V., Golikova A.A.
Pharmacoeconomic analysis of the use of dapagliflozin in patients with NYHA class II-IV chronic heart failure with reduced left ventricular ejection fraction <40% in the Russian Federation
Nedogoda S.V., Tereshhenko S.N., Zhirov I.V., Salasyuk A.S., Villevalde S.V., Barykina I.N., Lutova V.O., Popova E.A.
OPTIMIZATION OF PHARMACOTHERAPY IN A POLYMORBID PATIENT WITH A COMBINATION OF CHRONIC HEART FAILURE AND CHRONIC KIDNEY DISEASE. CLINICAL CASE
Ostroumova O.D., Aliautdinova I.A., Butorov V.N., Kochetkov A.I.
Captopril in cardiovascular disease management
Terpigorev S.A., Nikishenkov A.M., Kabanova T.G., Zadionchenko V.S., Yalymov A.A., Shekhyan G.G., Shchikota A.M., Ivanova N.A., Bogatyrova K.M.
The evolution of mineralocorticoid receptor antagonists: spironolactone and eplerenone
Leonova M.V., Alimova E.E., Eremina Y.N.
Possibilities of perindopril and ivabradin in patients with hypertensive disease in the normalization of hemodynamics, myocardial dysfunction and vascular endothelium
Ivanova O.F., Lebedev P.A., Vvedenskaya I.P., Komarova M.V., Paranina E.V.
1 - 87 of 87 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies